Cargando…

Effect of aggressive diuresis in acute heart failure with reduced and preserved ejection fraction

AIMS: Heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF) had distinct haemodynamic characteristics in the setting of acute heart failure. The aim of our study is to evaluate the differential response to aggressive diuresis in HFrEF and HFp...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Xin, Dong, Bin, Xue, Ruicong, Zhao, Jingjing, Wu, Zexuan, Wu, Yuzhong, Zhou, Yuanyuan, Wu, Dexi, Dong, Yugang, He, Jiangui, Liu, Chen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318499/ https://www.ncbi.nlm.nih.gov/pubmed/34076960 http://dx.doi.org/10.1002/ehf2.13453

Ejemplares similares

Influence of polypharmacy on patients with heart failure with preserved ejection fraction: a retrospective analysis on adverse outcomes in the TOPCAT trial
por: Wu, Yuzhong, et al.
Publicado: (2020)

C(2)HEST score predicts clinical outcomes in heart failure with preserved ejection fraction: a secondary analysis of the TOPCAT trial
por: Liang, Weihao, et al.
Publicado: (2021)

Clinical implication of pulmonary hospitalization in heart failure with preserved ejection fraction: from the TOPCAT
por: Dong, Bin, et al.
Publicado: (2020)

Usefulness of CHADS2, R2CHADS2, and CHA2DS2‐VASc scores for predicting incident atrial fibrillation in heart failure with preserved ejection fraction patients
por: Wu, Yuzhong, et al.
Publicado: (2021)

Clinical Significance of Mean and Pulse Pressure in Patients With Heart Failure With Preserved Ejection Fraction
por: Wei, Fang-Fei, et al.
Publicado: (2021)

Association of Body-Weight Fluctuation With Outcomes in Heart Failure With Preserved Ejection Fraction
por: Li, Yi, et al.
Publicado: (2021)

Phenotypes of heart failure with preserved ejection fraction and effect of spironolactone treatment
por: Choy, Manting, et al.
Publicado: (2022)

Weight Change and Mortality Risk in Heart Failure With Preserved Ejection Fraction
por: Huang, Peisen, et al.
Publicado: (2021)

Prognostic Implication of Liver Function Tests in Heart Failure With Preserved Ejection Fraction Without Chronic Hepatic Diseases: Insight From TOPCAT Trial
por: Liang, Weihao, et al.
Publicado: (2021)

Distinct implications of body mass index in different subgroups of nonobese patients with heart failure with preserved ejection fraction: a latent class analysis of data from the TOPCAT trial
por: Dong, Bin, et al.
Publicado: (2022)

Mean corpuscular haemoglobin concentration and outcomes in heart failure with preserved ejection fraction
por: Choy, Manting, et al.
Publicado: (2023)

Role of Exosomal miRNAs in Heart Failure
por: Xue, Ruicong, et al.
Publicado: (2020)

Sex-Specific Associations of Risks and Cardiac Structure and Function With Microalbumin/Creatinine Ratio in Diastolic Heart Failure
por: Wei, Fang-Fei, et al.
Publicado: (2020)

Non-vitamin K antagonist oral anticoagulants versus warfarin in atrial fibrillation patients with heart failure and preserved, mildly reduced, and reduced ejection fraction: A systemic review and meta-analysis
por: Wulamiding, Kaisaier, et al.
Publicado: (2022)

Associations of Left Ventricular Structure and Function With Blood Pressure in Heart Failure With Preserved Ejection Fraction: Analysis of the TOPCAT Trial
por: Wei, Fang‐Fei, et al.
Publicado: (2020)

Heart failure with preserved ejection fraction
por: Rigolli, Marzia, et al.
Publicado: (2013)

Heart failure with preserved ejection fraction
por: ElGuindy, Ahmed, et al.
Publicado: (2012)

Comparison of liver fibrosis scores for predicting mortality and morbidity in heart failure with preserved ejection fraction
por: Cao, Yalin, et al.
Publicado: (2023)

Natriuresis, Diuresis, and Volume Changes in Diabetics With Heart Failure With Preserved Ejection Fraction: Impact of Sodium‐Glucose Cotransporter 2 Inhibitors on Natriuretic Peptides
por: Silva Enciso, J.
Publicado: (2020)

Association of household secondhand smoke exposure and mortality risk in patients with heart failure
por: He, Xin, et al.
Publicado: (2019)

Biomarkers in heart failure with preserved ejection fraction
por: Meijers, W. C., et al.
Publicado: (2016)

Management of heart failure with preserved ejection fraction
por: Gard, Emma, et al.
Publicado: (2020)

Managing heart failure with preserved ejection fraction
por: Davidson, Alexander, et al.
Publicado: (2020)

Biomarkers in Heart Failure with Preserved Ejection Fraction
por: Bayes-Genis, Antoni, et al.
Publicado: (2022)

Comorbidities in heart failure with preserved ejection fraction
por: Deichl, Andrea, et al.
Publicado: (2022)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Associations of short‐ and long‐term mortality with admission blood pressure in Chinese patients with different heart failure subtypes
por: Chen, Shilan, et al.
Publicado: (2022)

Prognostic Value of Anxiety Between Heart Failure With Reduced Ejection Fraction and Heart Failure With Preserved Ejection Fraction
por: Lin, Tin‐Kwang, et al.
Publicado: (2019)

Evaluation of Adherence to Guideline for Heart Failure with Reduced Ejection Fraction in Heart Failure with Preserved Ejection Fraction and with or without Atrial Fibrillation
por: Ahn, Min-Soo, et al.
Publicado: (2021)

Association of Systemic Trimethyllysine With Heart Failure With Preserved Ejection Fraction and Cardiovascular Events
por: Wei, Haoran, et al.
Publicado: (2022)

Right Heart Phenotype in Heart Failure With Preserved Ejection Fraction
por: Guazzi, Marco, et al.
Publicado: (2021)

Metabolomic Fingerprint of Heart Failure with Preserved Ejection Fraction
por: Zordoky, Beshay N., et al.
Publicado: (2015)

Clinical Phenotypes in Heart Failure With Preserved Ejection Fraction
por: Samson, Rohan, et al.
Publicado: (2016)

Animal models of heart failure with preserved ejection fraction
por: Conceição, G., et al.
Publicado: (2016)

Cell Therapy for Heart Failure With Preserved Ejection Fraction
por: Borlaug, Barry A., et al.
Publicado: (2016)

Hospitalisation in Patients With Heart Failure With Preserved Ejection Fraction
por: Nanayakkara, Shane, et al.
Publicado: (2018)

Modelling the complexity of heart failure with preserved ejection fraction
por: O’Gallagher, Kevin, et al.
Publicado: (2018)

Microvascular Rarefaction and Heart Failure With Preserved Ejection Fraction
por: Zeng, Heng, et al.
Publicado: (2019)

Heart Failure With Preserved Ejection Fraction: An Opportunity for Reflection
por: Gupta, Deepak K.
Publicado: (2017)

Strategies for management of heart failure with preserved ejection fraction
por: Winchester, David E.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cm06ks0lkednd2sckeg6vt5s3a